Disclaimer: Our technologies are in development and have not been evaluated or approved by the FDA or any regulatory body. This content is for informational purposes only, it is not currently available for sale.

Call to action

Global Emergency

  • Sepsis: 166M cases and 21M deaths in a single year.
  • Superbugs and fungi already kill millions annually.
  • AMR could cause 10M deaths per year by 2050.

Economic Shockwave

  • AMR adds ≈$66B/year now, rising toward $159B.
  • Superbugs may cost the world up to $100T by 2050.
  • Every dollar invested can return 28 in benefits.

Americas Under Pressure

  • Sepsis drives tens of billions in hospital costs yearly.
  • MRSA, ESBL E. coli/Klebsiella, CRE strain ICUs daily.
  • Invasive Candida and endemic fungi raise mortality.

Europe’s Resistant Storm

  • Europe spends billions managing resistant infections.
  • Carbapenem-resistant Klebsiella and MRSA are entrenched.
  • Azole-resistant Aspergillus threatens cancer and ICU care.

Africa’s High Toll

  • Africa carries the world’s highest AMR death rates.
  • ESBL Enterobacterales and MRSA drive severe sepsis.
  • Cryptococcus, Candida, Aspergillus hit HIV/TB hardest.

Asia & Middle East Epicenter

  • Asia leads global AMR deaths; rates still climbing.
  • ESBL/CRE E. coli, Klebsiella, XDR Acinetobacter dominate ICUs.
  • C. auris and azole-resistant Aspergillus are spreading.

The Fungal Front

  • ≈6.5M invasive fungal infections, 3.8M deaths yearly.
  • Candida bloodstream infections can kill most patients.
  • Rapid fungal–bacterial diagnostics remain rare at bedside.

Innovation or Regression

  • MDR threats are eroding the safety of modern medicine.
  • We need faster diagnostics, new drugs, and prevention tech.
  • Partner with us to accelerate life-saving innovation now.

Explore the Evidence